- Jun. 27, 2018
- Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
- May 7, 2018
- National Cancer Center and Carna Biosciences Announce Research Collaboration for new drug discovery
- Feb. 14, 2018
- A secondary RET mutation in the activation loop conferring
resistance to vandetanib through allosteric effects - Jan. 23, 2018
- Precise cancer risk estimation based upon measurement of mutations and aberrant DNA methylation accumulated in normal tissues
association between the accumulation and life style